Delfina “Fini” Lanusse and Hernán Boveri were identified on Apr. 3 as the primary suspects in a judicial investigation concerning the so-called “Propo Fest” events, which have shaken Buenos Aires’ private health system.
The case is significant because it involves allegations of fraudulent administration and theft of hospital drugs, raising concerns about drug control and safety within medical institutions.
Lanusse, formerly a medical resident known for her social media presence, reportedly displayed a lifestyle that exceeded what would be expected from her salary. This online exposure became critical when authorities began tracking missing pharmaceuticals. Boveri, an experienced anesthesiologist, had privileged access to controlled substances such as propofol and fentanyl. Investigators say the two maintained an extramarital relationship that may have facilitated unauthorized use of hospital medications.
The investigation gained momentum after the unexplained death of anesthesiologist Zalazar revealed details about private gatherings referred to as “Propo Fest.” These events allegedly involved recreational use of potent anesthetics like fentanyl—sometimes called the “zombie drug” due to its dangers—which were reportedly diverted from hospital supplies by falsifying patient records or reporting false discards.
As the inquiry unfolded before judicial authorities, both suspects offered conflicting statements. Lanusse admitted to using drugs but described herself as a victim who was supplied substances by Boveri over two years. In contrast, Boveri acknowledged administering drugs to Lanusse but claimed she was responsible for stealing them from Hospital Italiano by exploiting her access to storage areas.
Both professionals now face charges related to fraudulent administration and theft of pharmaceuticals. The court is working under secrecy provisions to determine whether other medical staff were involved or if proceeds from illicit sales funded Lanusse’s luxury lifestyle.
The outcome of this case could influence future oversight practices in hospitals and shape public discussion around drug diversion risks among healthcare workers.
